Bio-link Australia Pty. Ltd.

5th February 2013 – Bio-Link Engaged by Phylogica Ltd.

Bio-Link has been engaged by Phylogica Ltd. (ASX: PYC, XETRA: PH7), to provide business development services for a family of its anti-inflammatory Phylomer® peptides, which target the AP-1 pathway and have demonstrated efficacy in multiple preclinical models of stroke, traumatic brain injury and acute respiratory distress syndrome (ARDS) .
Click here for the full press release